Zosano Pharma Corporation

    Zosano Pharma Corporation

    NNASDAQ:ZSAN
    - -
    USD
    - -
    - -
    No data availableFinancial data will appear here once available

    Capital Structure

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Working Capital

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Growth Rates

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Quarterly Revenue

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Quarterly Earnings Per Share

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Quarterly Dividends Per Share

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Company Description

    Address
    Similar Companies
    Business

    Company News

    • Microneedles for Drug Delivery Patent Landscape Report and Forecast 2024-2032, Featuring Minnesota Mining and Manufacturing, BD and Co, Zosano Pharma, Raphas, Nano, and Pass Technologies

    • Why Zosano Pharma Shares Are Getting Hammered Today

    • Zosano Pharma Reports First Quarter 2022 Financial Results

    • Zosano Pharma Announces Additional Workforce Layoff

    • Zosano Pharma Provides Corporate Update

    • Is Zosano Pharma (ZSAN) Stock Really Up 3,000% Today?

    • Zosano Pharma (ZSAN) Stock: 1-For-35 Reverse Split Goes Into Effect

    • Zosano Pharma Announces Reverse Stock Split Effective Today

    • Best Stocks to Buy Under $5? Check These 3 Out

    • Zosano Pharma Reports Fourth Quarter and Fiscal Year 2021 Financial Results

    • Zosano Pharma (ZSAN) Stock: Why The Price Substantially Fell Today

    • Zosano Pharma Announces Pricing of $15.4 Million Public Offering of Common Stock and Warrants

    • Zosano Pharma Announces Proposed Public Offering of Common Stock and Warrants

    • CORRECTION - Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher Dose

    • Zosano Pharma Announces Publication Of Early Data On Influenza Vaccine

    • Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher Dose

    • Zosano Pharma Announces Changes to Board of Directors; Appoints Cross Functional Business Executive Elaine M. Yang

    • Today's Hot Penny Stocks: What's Moving ZSAN, AVGR and CEI Higher Wednesday?

    • Zosano Pharma Corporation (ZSAN) Reports Q3 Loss, Misses Revenue Estimates

    • Zosano Pharma Reports Third Quarter 2021 Financial Results